Literature DB >> 21339229

Imaging of axial spondyloarthritis including ankylosing spondylitis.

J Braun1, X Baraliakos.   

Abstract

New bone formation of the vertebral column is pathognomonic for ankylosing spondylitis (AS), while acute and/or chronic changes in the sacroiliac joints are relevant for diagnosis. The 'gold standard' for assessment of structural changes in AS are conventional radiographs, while MRI is useful to assess inflammation. Recent MRI studies have shown that the lower half of the thoracic spine is most commonly affected in AS. Scoring tools for spinal inflammation such as the ASspiMRI-a have been proposed, successfully used in large clinical trials and compared in a multireader experiment; none was finally preferred by OMERACT. Quantification of structural spinal AS changes is performed by the modified Stokes AS Spine Score (mSASSS), which evaluates lateral cervical and lumbar radiographs. Two years was identified as the shortest possible follow-up time based on the reliability and sensitivity to change of the mSASSS. A potential disadvantage of the mSASSS is that the thoracic spine is not included. Recent data based on the mSASSS have suggested that tumour necrosis factor blockers do not inhibit radiographic progression in AS. Since the mean radiographic change is reported to be less than 1 syndesmophyte over 2 years, the sensitivity to change of the mSASSS has been questioned. However, in one study where continuous non-steroidal anti-inflammatory drugs use was compared with on-demand use, a difference between these two methods of drug intake was reported. The face and construct validity of the mSASSS has been criticised because a score of ´1´ contains a mixture of osteodestructive (erosions) and osteoproliferative changes (squaring and sclerosis). A new scoring system, the RASSS, which concentrates only on bone formation and which includes the lower part of the thoracic spine is currently being evaluated. The relationship between inflammation and new bone formation in AS has recently been investigated. Low sclerostin and DKK-1 serum levels, both inhibitors of bone formation, were found to be associated with syndesmophyte formation in patients with AS.

Entities:  

Mesh:

Year:  2011        PMID: 21339229     DOI: 10.1136/ard.2010.140541

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  26 in total

1.  Spondyloarthropathies: the disease process in axial SpA: what can biomarkers tell us?

Authors:  Jürgen Braun; Xenofon Baraliakos
Journal:  Nat Rev Rheumatol       Date:  2011-12-23       Impact factor: 20.543

Review 2.  The balance of tissue repair and remodeling in chronic arthritis.

Authors:  Rik Lories
Journal:  Nat Rev Rheumatol       Date:  2011-10-18       Impact factor: 20.543

3.  Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis.

Authors:  Yong-Gil Kim; Dong Hyun Sohn; Xiaoyan Zhao; Jeremy Sokolove; Tamsin M Lindstrom; Bin Yoo; Chang-Keun Lee; John D Reveille; Joel D Taurog; William H Robinson
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

4.  Classification criteria for spondyloarthropathies.

Authors:  Ozgur Akgul; Salih Ozgocmen
Journal:  World J Orthop       Date:  2011-12-18

5.  Correlation between clinical and MRI disease activity scores in axial spondyloarthritis.

Authors:  James W MacKay; Sharief Aboelmagd; J Karl Gaffney
Journal:  Clin Rheumatol       Date:  2015-04-19       Impact factor: 2.980

6.  Inflammatory bowel disease associated arthropathy.

Authors:  Sheila L Arvikar; Mark C Fisher
Journal:  Curr Rev Musculoskelet Med       Date:  2011-09

7.  The IgG galactosylation ratio is higher in spondyloarthritis patients and associated with the MRI score.

Authors:  Jing Liu; Qi Zhu; Jing Han; Hui Zhang; Yuan Li; Yanyun Ma; Hengdong Ji; Dongyi He; Jianxin Gu; Xiaodong Zhou; John D Reveille; Li Jin; Hejian Zou; Shifang Ren; Jiucun Wang
Journal:  Clin Rheumatol       Date:  2020-03-02       Impact factor: 2.980

8.  Lower frequency of obstructive sleep apnea in spondyloarthritis patients taking TNF-inhibitors.

Authors:  Jessica A Walsh; Kristina Callis Duffin; Julia Crim; Daniel O Clegg
Journal:  J Clin Sleep Med       Date:  2012-12-15       Impact factor: 4.062

9.  Bone edema of the whole vertebral body: an unusual case of spondyloarthritis.

Authors:  Augusta Ortolan; Paolo Lazzarin; Mariagrazia Lorenzin; Lucia Rampin; Roberta Ramonda
Journal:  Clin Rheumatol       Date:  2016-09-27       Impact factor: 2.980

10.  Analysis and performance of various classification criteria sets in a Colombian cohort of patients with spondyloarthritis.

Authors:  Wilson Bautista-Molano; Robert B M Landewé; John Londoño; Consuelo Romero-Sanchez; Rafael Valle-Oñate; Désirée van der Heijde
Journal:  Clin Rheumatol       Date:  2016-01-21       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.